SNMMI Clinical Trials Network (CTN) Research Series for Technologists: "Clinical Research Primer - Regulatory Process Part I: How and when Radiopharmaceuticals Can be Used"

This article will familiarize the reader with the U.S. regulatory process by providing basic definitions and understanding of how and when radiopharmaceuticals can be used in clinical research including those involving investigational new drug (IND) applications and radioactive drug research committees (RDRCs). A later article will expand the reader's clinical research knowledge by focusing on the identity and role of the institutional review board (IRB).PMID:34933923 | DOI:10.2967/jnmt.121.263499
Source: Journal of Nuclear Medicine Technology - Category: Nuclear Medicine Authors: Source Type: research